Learn how gene editing is transforming sickle cell disease treatment and why expanding access to younger children matters.
Gene editing has delivered remarkable results against sickle cell disease. Now researchers are working to make these ...
A 23-year-old man from Louisiana has become one of the first people in the United States to be functionally cured of sickle cell disease using Casgevy, the world's first approved CRISPR-based ...
Regulators have opened a one-time gene therapy to some of the youngest patients with sickle cell disease. On July 1, 2026, ...
FDA expands Casgevy CRISPR gene therapy to children aged 2+ with sickle cell disease and beta thalassemia, enabling earlier ...
Recent data published in NEJM demonstrates that CRISPR gene-editing therapy achieves complete clinical efficacy endpoints in ...
The U.S. Food and Drug Administration (FDA) on Friday announced that it has approved Casgevy, the first CRISPR gene-editing therapy for sickle cell disease, paving the way for thousands of patients in ...
New research led by a Nashville physician is offering hope to children with sickle cell disease and another inherited blood ...
Daniel Cressy, 23, has become the first person in the Gulf South to become functionally cured of sickle cell disease using ...
Scientists are seeing promising early results from the first studies testing gene editing for painful, inherited blood disorders that plague millions worldwide, especially Black people. Doctors hope ...
New research shows it’s possible to edit the DNA of human embryos with more precision. But scientists warn it’s still not ...